Why is There Still Debate About Recommending DPYD-Testing Before Fluoropyrimidine Treatment?

Clin Pharmacol Ther

Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.

Published: October 2023

Download full-text PDF

Source
http://dx.doi.org/10.1002/cpt.3016DOI Listing

Publication Analysis

Top Keywords

debate recommending
4
recommending dpyd-testing
4
dpyd-testing fluoropyrimidine
4
fluoropyrimidine treatment?
4
debate
1
dpyd-testing
1
fluoropyrimidine
1
treatment?
1

Similar Publications

Background: Neoadjuvant therapy is recommended for treating resectable pancreatic ductal adenocarcinoma (PDAC); however, its appropriate use in patients with resectable PDAC remains debatable.

Objective: This study aimed to identify independent poor prognostic factors and evaluate the clinical significance of neoadjuvant therapy in patients with resectable PDAC.

Methods: We retrospectively reviewed consecutive patients diagnosed with resectable PDAC at our institute between January 2003 and December 2022.

View Article and Find Full Text PDF

Ovarian clear cell carcinoma (OCCC) accounts for ~10% of all epithelial ovarian cancers and is considered a different entity from the more common high-grade serous ovarian carcinoma (HGSC), with distinct clinical presentations, different risk, and prognostic factors, and specific molecular features. Most OCCCs are diagnosed at an early stage and show favorable outcomes, in contrast to those diagnosed at advanced stages, which exhibit intrinsic resistance to platinum-based chemotherapy regimens and a very poor prognosis. The standard treatment of advanced OCCC is currently based on primary debulking surgery followed by platinum-based chemotherapy according to recent international guidelines.

View Article and Find Full Text PDF

Introduction: Attention-deficit hyperactivity disorder (ADHD) is a neuropsychiatric condition that affects children. Its magnitude varies by area, ranging from 0.2% to 26.

View Article and Find Full Text PDF

Three months before the planned implementation of the European Union Regulation on Deforestation-free products, the European Commission proposed to postpone the implementation by twelve months. The announcement raised the temperature in the debate on this regulation. We put forward suggestions, based on scientific knowledge as well as current EUDR research and implementation projects, on how the 12-month phasing-in period could be used wisely to promote sustainability transitions in deforestation-risk value chains.

View Article and Find Full Text PDF

Unlabelled: Since the inception of transplantation, it has been crucial to ensure that organ or tissue donations are made with valid informed consent to avoid concerns about coercion or exploitation. This issue is particularly challenging when it comes to infants and younger children, insofar as they are unable to provide consent. Despite their vulnerability, infants' organs and tissues are considered valuable for biomedical purposes due to their size and unique properties.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!